🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
NeoImmuneTech, Inc. (KOSDAQ:950220)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,410.00
-75.00 (-5.05%)
Nov 20, 2026, 3:30 PM KST

NeoImmuneTech Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6,60294.82170.38---
Revenue Growth
6902.30%-44.35%----
Gross Profit
4,39894.82170.38---
Selling, General & Admin
21,95522,81736,53452,36955,32650,090
Amortization of Goodwill & Intangibles
1,310655.52529.12506.4501.18443.95
Operating Expenses
25,02925,43441,14355,84758,18251,906
Operating Income
-20,631-25,339-40,972-55,847-58,182-51,906
Interest Expense
-2,545-2,424-726.09-225.28-261.39-219.15
Interest & Investment Income
1,4121,2551,7882,8771,154390.88
Currency Exchange Gain (Loss)
-1,984-1,859-1,335-128.89-3,005-589.4
Other Non Operating Income (Expenses)
978.75-3,6141,18723.0618.5215.46
EBT Excluding Unusual Items
-22,768-31,981-40,059-53,301-60,276-52,308
Gain (Loss) on Sale of Assets
-39.87213.95-321.85-1.91-13.03-104.72
Asset Writedown
0.07-40.1-488.92---
Pretax Income
-22,808-31,807-40,870-53,303-60,289-52,413
Income Tax Expense
37.43-11.3712.83101.3116.4169.47
Net Income
-22,846-31,796-40,883-53,405-60,406-52,482
Net Income to Common
-22,846-31,796-40,883-53,405-60,406-52,482
Net Income Growth
------
Shares Outstanding (Basic)
12811899999995
Shares Outstanding (Diluted)
12811899999995
Shares Change
220.31%19.34%-0.24%0.08%3.68%15.27%
EPS (Basic)
-179.07-270.20-414.60-540.26-611.60-550.94
EPS (Diluted)
-179.07-270.20-414.60-540.40-611.60-550.94
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-17,316-25,133-40,612-50,552-44,881-36,596
Free Cash Flow Per Share
-135.73-213.57-411.85-511.40-454.42-384.18
Gross Margin
66.61%100.00%100.00%---
Operating Margin
-312.48%-26721.84%-24047.07%---
Profit Margin
-346.02%-33531.39%-23994.58%---
Free Cash Flow Margin
-262.28%-26504.37%-23835.33%---
EBITDA
-17,773-22,841-37,299-52,637-55,380-50,033
D&A For EBITDA
2,8582,4983,6733,2102,8021,873
EBIT
-20,631-25,339-40,972-55,847-58,182-51,906